Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Peter A. Calabresi | Researchclopedia

Back to researchers

Peter A. Calabresi

Johns Hopkins University ORCID

908

Works

59,825

Citations

111

h-index

508

i10-index

Research Topics

Multiple Sclerosis Research Studies Neuroinflammation and Neurodegeneration Mechanisms Systemic Lupus Erythematosus Research

Affiliations

Boston University2022–2022

University of Rome Tor Vergata1996–2004

University of Hawaiʻi at Mānoa2013–2013

Tufts University2022–2022

Western University2019–2019

Top Works

Defining the clinical course of multiple sclerosis

Fred Lublin,Stephen C. Reingold,et al.

20143,051 citations

Retinal and Optic Conditions

Glaucoma and retinal disorders

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos,Ernst‐Wilhelm Radue,et al.

20102,604 citations

Multiple Sclerosis

Daniel S. Reich,Claudia F. Lucchinetti,et al.

20182,359 citations

Tract probability maps in stereotaxic spaces: Analyses of white matter anatomy and tract-specific quantification

Kegang Hua,Jiangyang Zhang,et al.

20071,552 citations

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Richard A. Rudick,William H. Stuart,et al.

20061,331 citations

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial

Kathleen Hawker,Paul O’Connor,et al.

2009928 citations

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Peter A. Calabresi,Ernst-Wilhelm Radüe,et al.

2014820 citations

Saccade preparation inhibits reorienting to recently attended locations.

Robert D. Rafal,Peter A. Calabresi,et al.

1989791 citations

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

Ludwig Kappos,David Li,et al.

2011731 citations